SCHEMBL3437320

SCHEMBL3437320

C=CC(=O)OCCCCOc1ccc(-c2ccc(/C=C/C(=O)Oc3ccc(CCOC(=O)C=C)cc3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.52
CA4 P22748 4/20 0.52
CA6 P23280 4/20 0.52
CA5A P35218 4/20 0.52
CA7 P43166 4/20 0.52
CA9 Q16790 4/20 0.52
CA14 Q9ULX7 4/20 0.52
CA5B Q9Y2D0 4/20 0.52
CA1 P00915 3/20 0.52
MET P08581 3/20 0.52
AKR1B10 O60218 4/20 0.47
AKR1B1 P15121 4/20 0.47
MAOB P27338 1/20 0.46
THRB P10828 3/20 0.46
APP P05067 3/20 0.43
CYP3A4 P08684 2/20 0.41
ALOX15 P16050 2/20 0.41
ALOX12 P18054 2/20 0.41
MAPK1 P28482 2/20 0.41
HSD17B10 Q99714 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3437306 0.99 CA12 (0.51) CA12CA4CA6CA5ACA7
SCHEMBL22219380 0.94 CA12 (0.46) CA12CA4CA6CA5ACA7
SCHEMBL3437307 0.92 CA12 (0.46) CA12CA4CA6CA5ACA7
SCHEMBL3437321 0.92 THRB (0.48) CA12CA4CA6CA5ACA7
SCHEMBL3437297 0.92 MET (0.58) CA12CA4CA6CA5ACA7
SCHEMBL3437285 0.92 MET (0.58) CA12CA4CA6CA5ACA7
SCHEMBL18926017 0.91 CA12 (0.46) CA12CA4CA6CA5ACA7
SCHEMBL13750820 0.91 THRB (0.51) CA12CA4CA6CA5ACA7
SCHEMBL3437309 0.91 THRB (0.47) AKR1B10AKR1B1THRBAPPCYP3A4
SCHEMBL21234582 0.91 CA12 (0.48) CA12CA4CA6CA5ACA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11312906-B2 Polymerizable monomer, liquid crystal composition using polymerizable monomer, and liquid crystal display device DIC CORPORATION (JP) 2022-04-26 US disclosed
EP-3450523-B1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE DAINIPPON INK & CHEMICALS (JP) 2021-01-06 EP disclosed
US-20200224098-A1 POLYMERIZABLE MONOMER, LIQUID CRYSTAL COMPOSITION USING POLYMERIZABLE MONOMER, AND LIQUID CRYSTAL DISPLAY DEVICE DIC CORPORATION (JP) 2020-07-16 US disclosed
US-20200208054-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT DIC Corporation (Tokyo) (JP) 2020-07-02 US disclosed
US-10690952-B2 Liquid crystal display element DIC CORPORATION (JP) 2020-06-23 US disclosed
US-10633590-B2 Liquid crystal composition and liquid crystal display device including the same DIC CORPORATION (JP) 2020-04-28 US disclosed
US-10465113-B2 Nematic liquid crystal composition, and liquid crystal display element manufactured using same DIC CORPORATION (JP) 2019-11-05 US disclosed
US-10351772-B2 Nematic liquid crystal composition and liquid crystal display element using same DIC CORPORATION (JP) 2019-07-16 US disclosed
EP-3173457-B1 LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY ELEMENT OBTAINED USING SAME DAINIPPON INK & CHEMICALS (JP) 2019-06-05 EP disclosed
US-20190119575-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT DIC CORPORATION (JP) 2019-04-25 US disclosed
US-20160075947-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME DIC CORPORATION (JP) 2016-03-17 US disclosed
US-9260661-B2 Nematic liquid crystal composition and liquid crystal display element including the same DIC CORPORATION (JP) 2016-02-16 US disclosed
US-9260661-B2 Nematic liquid crystal composition and liquid crystal display element including the same DIC CORPORATION (JP) 2016-02-16 US disclosed
US-20150315469-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME DIC Corporation (Tokyo) (JP) 2015-11-05 US disclosed
US-20150315469-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME DIC Corporation (Tokyo) (JP) 2015-11-05 US disclosed
US-20150218450-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT INCLUDING THE SAME DIC CORPORATION (JP) 2015-08-06 US disclosed
US-20150218450-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT INCLUDING THE SAME DIC CORPORATION (JP) 2015-08-06 US disclosed
EP-2883935-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME DIC Corporation (JP) 2015-06-17 EP disclosed
US-20120097895-A1 LIQUID CRYSTAL COMPOSITION CONTAINING POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME DIC CORPORATION (JP) 2012-04-26 US disclosed
US-20120097895-A1 LIQUID CRYSTAL COMPOSITION CONTAINING POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME DIC CORPORATION (JP) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10465113-B2 Nematic liquid crystal composition, and liquid crystal display element manufactured using same LBR, VSIR, KIF23 CA12 2052/4885CA4 3297/4885CA6 3784/4885
US-10633590-B2 Liquid crystal composition and liquid crystal display device including the same LASP1, UACA, CCDC22 CA12 1981/4885CA4 2318/4885CA6 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.